Heart Attack

Study lifts cloud over heart drugs Zetia, Vytorin

A major study lifts a cloud around Zetia and Vytorin, blockbuster drugs for lowering cholesterol. The study found that these pills modestly lower the risk of heart attacks and other problems in people at ...

Nov 17, 2014
popularity not rated yet | comments 0

Beta blockers could benefit patients with HFPEF

A novel registry study from Karolinska Institutet in Sweden suggests that beta blockers may benefit also patients suffering from a relatively unknown form of heart failure called HFPEF, which today lacks ...

Nov 16, 2014
popularity 5 / 5 (1) | comments 0

Latest Spotlight News

Researcher to cancer: 'Resistance will be futile'

Turning the tables, Katherine Borden at the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) has evoked Star Trek's Borg in her fight against the disease. "Cancer cells rapidly ...

Stem cells faulty in Duchenne muscular dystrophy

Like human patients, mice with a form of Duchenne muscular dystrophy undergo progressive muscle degeneration and accumulate connective tissue as they age. Now, researchers at the Stanford University School of Medicine have ...

Multiple allergic reactions traced to single protein

Johns Hopkins and University of Alberta researchers have identified a single protein as the root of painful and dangerous allergic reactions to a range of medications and other substances. If a new drug can ...